Medical device licence · 1460 · Class 2
UNICAP/PHARMACIA CAP SYSTEM
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed February 22, 1999; ended October 24, 2007. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 1460
- Licence holder
- Phadia AbUppsala, Sweden
- Risk class
- Class II (low to moderate risk)
- Licence type
- System
- First licensed
- February 22, 1999
- Ended
- October 24, 2007
- Devices covered
- 12
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- UNICAP 100 SYSTEM (AUTO ANALYZER)
- UNICAP ECP (EOSINOPHIL CATIONIC PROTEIN) FLUOROIMMUNOASSAY
- UNICAP IGE RIA REAGENTS
- UNICAP PHADIATOP FLUOROIMMUNOASSAY
- UNICAP PHARMACIA CAP SYSTEM ALLERGENS
- UNICAP SPECIFIC IGA FLUOROENZYMEIMMUNOASSAY
- UNICAP SPECIFIC IGE FLUOROIMMUNOASSAY
- UNICAP SPECIFIC IGG FLUOROENZIMEIMMUNOASSAY
- UNICAP THYROGLOBULIN IMMUNOCAP
- UNICAP THYROID PEROXIDASE IMMUNOCAP
- UNICAP/PHARMACIA CAP SYSTEM - ELIA GLIADIN IGA ASSAY
- UNICAP/PHARMACIA CAP SYSTEM - ELIA GLIADIN IGG ASSAY
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.